Among patients who received four-drug consolidation therapy, 84% had measurable residual disease (MRD)-negative status before ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

These mutated diseases defy the power of antibiotics. Are illnesses really mutating so fast that we can’t stay ahead of them?

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

A ctDNA-guided approach can help identify when patients with HR-positive advanced breast cancer are developing an ESR1 ...

GlaxoSmithKline (GSK – Research Report) received a Hold rating and a $41.00 price target from Berenberg Bank analyst Kerry Holford today. Confident Investing Starts Here: Easily ...

NEW YORK, DE, UNITED STATES, June 6, 2025 /EINPresswire.com/ -- The global nasal sprays market is projected to grow from USD ...

NIGERIA’S pharmaceutical sector is hampered by import dependency and years of economic and infrastructural shocks. The ...

June 3, 2025 expert reaction to observational study on low calorie diets and depressive symptoms . An observational study published in BMJ Nutrition, Prevention & Health looks at ...

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...